BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Dorota Diakowska, Krystyna Markocka-Mączka, Piotr Szelachowski, Krzysztof Grabowski. Serum Levels of Resistin, Adiponectin, and Apelin in Gastroesophageal Cancer PatientsDisease Markers 2014; 2014: 1 doi: 10.1155/2014/619649
2
Michael J Tisdale. Cancer cachexiaCurrent Opinion in Gastroenterology 2010; 26(2): 146 doi: 10.1097/MOG.0b013e3283347e77
3
Oliver Grundmann, Saunjoo L. Yoon, Joseph J. Williams. Handbook of Famine, Starvation, and Nutrient Deprivation2017; : 1 doi: 10.1007/978-3-319-40007-5_56-1
4
Josep M Argilés, Britta Stemmler. The potential of ghrelin in the treatment of cancer cachexiaExpert Opinion on Biological Therapy 2013; 13(1): 67 doi: 10.1517/14712598.2013.727390
5
Satoshi Ugi, Yoshihiko Nishio, Hiroshi Yamamoto, Kazuhiro Ikeda, Masaaki Kobayashi, Shuichi Tsukada, Motoyuki Kondo, Katsutaro Morino, Toshiyuki Obata, Takeshi Yoshizaki, Takashi Uzu, Hiroyuki Naitoh, Toru Tani, Shiro Maeda, Atsunori Kashiwagi, Hiroshi Maegawa. Relation of the Expression of Transcriptional Factor TFAP2B to That of Adipokines in Subcutaneous and Omental Adipose TissuesObesity 2010; 18(7): 1277 doi: 10.1038/oby.2009.442
6
Lisa K. Chopin, Inge Seim, Carina M. Walpole, Adrian C. Herington. The Ghrelin Axis—Does It Have an Appetite for Cancer Progression?Endocrine Reviews 2012; 33(6): 849 doi: 10.1210/er.2011-1007
7
N. JOHNS, B. H. TAN, M. MACMILLAN, T. S. SOLHEIM, J. A. ROSS, V. E. BARACOS, S. DAMARAJU, K. C. H. FEARON. Genetic basis of interindividual susceptibility to cancer cachexia: selection of potential candidate gene polymorphisms for association studiesJournal of Genetics 2014; 93(3): 893 doi: 10.1007/s12041-014-0405-9
8
H. Suzuki, A. Asakawa, H. Amitani, N. Fujitsuka, N. Nakamura, A. Inui. Cancer Cachexia Pathophysiology and Translational Aspect of Herbal MedicineJapanese Journal of Clinical Oncology 2013; 43(7): 695 doi: 10.1093/jjco/hyt075
9
Takako Eguchi Nakajima, Yasuhide Yamada, Tetsutaro Hamano, Koh Furuta, Ichiro Oda, Hoichi Kato, Ken Kato, Tetsuya Hamaguchi, Yasuhiro Shimada. Adipocytokines and squamous cell carcinoma of the esophagusJournal of Cancer Research and Clinical Oncology 2010; 136(2): 261 doi: 10.1007/s00432-009-0657-6
10
Jeremy Steinman, Mark Daniel DeBoer. AnorexiaVitamins & Hormones 2013; 92: 197 doi: 10.1016/B978-0-12-410473-0.00008-8
11
S. Levolger, E. A. C. Wiemer, J. L. A. van Vugt, S. A. Huisman, M. G. van Vledder, S. van Damme-van Engel, G. Ambagtsheer, J. N. M. IJzermans, R. W. F. de Bruin. Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wastingScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-46178-9
12
Shailendra Kapoor. Re: Jehonathan H. Pinthus, Nir Kleinmann, Britton Tisdale, et al. Lower Plasma Adiponectin Levels Are Associated with Larger Tumor Size and Metastasis in Clear-Cell Carcinoma of the Kidney. Eur Urol 2008;54:866–74European Urology 2009; 55(3): e52 doi: 10.1016/j.eururo.2008.08.073
13
Flavia Prodam, Nicoletta Filigheddu. Ghrelin Gene Products in Acute and Chronic InflammationArchivum Immunologiae et Therapiae Experimentalis 2014; 62(5): 369 doi: 10.1007/s00005-014-0287-9
14
Arjun Gupta, Yehuda Herman, Colby Ayers, Muhammad S. Beg, Susan G. Lakoski, Shuaib M. Abdullah, David H. Johnson, Ian J. Neeland, David Meyre. Plasma Leptin Levels and Risk of Incident Cancer: Results from the Dallas Heart StudyPLOS ONE 2016; 11(9): e0162845 doi: 10.1371/journal.pone.0162845
15
L.M. Freeman. Cachexia and Sarcopenia: Emerging Syndromes of Importance in Dogs and CatsJournal of Veterinary Internal Medicine 2012; 26(1): 3 doi: 10.1111/j.1939-1676.2011.00838.x
16
M.L. Batista, M. Olivan, P.S.M. Alcantara, R. Sandoval, S.B. Peres, R.X. Neves, R. Silverio, L.F. Maximiano, J.P. Otoch, M. Seelaender. Adipose tissue-derived factors as potential biomarkers in cachectic cancer patientsCytokine 2013; 61(2): 532 doi: 10.1016/j.cyto.2012.10.023
17
Julia B. Ewaschuk, Alaa Almasud, Vera C. Mazurak. Role of n-3 fatty acids in muscle loss and myosteatosisApplied Physiology, Nutrition, and Metabolism 2014; 39(6): 654 doi: 10.1139/apnm-2013-0423
18
Takashi Akamizu, Kenji Kangawa. Therapeutic applications of ghrelin to cachexia utilizing its appetite-stimulating effectPeptides 2011; 32(11): 2295 doi: 10.1016/j.peptides.2011.05.018
19
Donald C. McMillan. The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancerCancer Treatment Reviews 2013; 39(5): 534 doi: 10.1016/j.ctrv.2012.08.003
20
Fabio Penna, Gabriella Bonelli, Francesco M. Baccino, Paola Costelli. AnorexiaVitamins & Hormones 2013; 92: 271 doi: 10.1016/B978-0-12-410473-0.00011-8
21
Kent Lundholm, Lena Gunnebo, Ulla Körner, Britt-Marie Iresjö, Cecilia Engström, Anders Hyltander, Ulrika Smedh, Ingvar Bosaeus. Effects by daily long term provision of ghrelin to unselected weight-losing cancer patientsCancer 2010; 116(8): 2044 doi: 10.1002/cncr.24917
22
Ross D Dolan, Stephen T McSorley, Paul G Horgan, Barry Laird, Donald C McMillan. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta -analysisCritical Reviews in Oncology/Hematology 2017; 116: 134 doi: 10.1016/j.critrevonc.2017.06.002
23
Jéssica V. Mansson, Fernanda D. Alves, Andréia Biolo, Gabriela C. Souza. Use of ghrelin in cachexia syndrome: a systematic review of clinical trialsNutrition Reviews 2016; 74(11): 659 doi: 10.1093/nutrit/nuw029
24
Josep M. Argilés, Britta Stemmler, Francisco J. López-Soriano, Silvia Busquets. Nonmuscle Tissues Contribution to Cancer CachexiaMediators of Inflammation 2015; 2015: 1 doi: 10.1155/2015/182872
25
Sumanta Dutta, Andrew B.C. Crumley, Grant M. Fullarton, Paul G. Horgan, Donald C. McMillan. Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancerThe American Journal of Surgery 2012; 204(3): 294 doi: 10.1016/j.amjsurg.2011.10.015
26
BENJAMIN H. L. TAN, JAMES A. ROSS, STEIN KAASA, FRANK SKORPEN, KENNETH C. H. FEARON. Identification of possible genetic polymorphisms involved in cancer cachexia: a systematic reviewJournal of Genetics 2011; 90(1): 165 doi: 10.1007/s12041-011-0027-4
27
Yunbao Pan, Fuling Zhou, Chenyan He, Lingyun Hui, Tianhe Huang, Yongchang Wei. Leptin-LepRb Expressed in Gastric Cancer Patients and Related to Cancer-Related DepressionBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/6482842
28
Ioannis Gioulbasanis, Athanasios Pallis, Panagiotis J. Vlachostergios, Alexandros Xyrafas, Zoe Giannousi, Isidora-Eleni Perdikouri, Michalitsa Makridou, Dionysia Kakalou, Vassilios Georgoulias. The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancerLung Cancer 2012; 77(2): 383 doi: 10.1016/j.lungcan.2012.04.008
29
Donald C McMillan. Systemic inflammation, nutritional status and survival in patients with cancerCurrent Opinion in Clinical Nutrition and Metabolic Care 2009; 12(3): 223 doi: 10.1097/MCO.0b013e32832a7902
30
Takashi Akamizu, Kenji Kangawa. Ghrelin for cachexiaJournal of Cachexia, Sarcopenia and Muscle 2010; 1(2): 169 doi: 10.1007/s13539-010-0011-5
31
Renata Silvério, Fábio S. Lira, Lila M. Oyama, Cláudia M. Oller do Nascimento, José P. Otoch, Paulo S. M. Alcântara, Miguel L. Batista, Marília Seelaender. Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancerLipids in Health and Disease 2017; 16(1) doi: 10.1186/s12944-017-0547-x
32
Zhenzhen Zhang, Jackilen Shannon, Hanrui Zhang. Adipocytokines, Energy Balance, and CancerEnergy Balance and Cancer 2017; 12: 187 doi: 10.1007/978-3-319-41677-9_9
33
Paraskevi Boura, Stylianos Loukides, Dimitra Grapsa, Apostolos Achimastos, Konstantinos Syrigos. The diverse roles of adiponectin in non-small-cell lung cancer: current data and future perspectivesFuture Oncology 2015; 11(15): 2193 doi: 10.2217/fon.15.96
34
Mohammadamin Sadeghi, Mahsa Keshavarz-Fathi, Vickie Baracos, Jann Arends, Maryam Mahmoudi, Nima Rezaei. Cancer cachexia: Diagnosis, assessment, and treatmentCritical Reviews in Oncology/Hematology 2018; 127: 91 doi: 10.1016/j.critrevonc.2018.05.006
35
Ilze Strumfa, Tatjana Bogdanova, Arturs Kalva, Boriss Strumfs, Roberts Rumba, Andrejs Vanags, Inese Drike, Dzeina Mezale, Arnis Abolins, Arvids Jakovlevs, Dainis Balodis, Janis Gardovskis. Gastric Cancer2017;  doi: 10.5772/intechopen.69723
36
Paraskevi Boura, Dimitra Grapsa, Stylianos Loukides, Maria Angelidou, Konstantina Tsakanika, Nikolaos Syrigos, Ioannis Gkiozos. The prognostic value of serum and bronchoalveolar lavage levels of adiponectin in advanced non-small-cell lung cancerLung Cancer Management 2017; 6(2): 55 doi: 10.2217/lmt-2016-0018
37
Tomoya Tsukada, Sachio Fushida, Shinichi Harada, Shiroh Terai, Yasumichi Yagi, Jun Kinoshita, Katsunobu Oyama, Hidehiro Tajima, Hideto Fujita, Itasu Ninomiya, Takashi Fujimura, Tetsuo Ohta. Adiponectin receptor-1 expression is associated with good prognosis in gastric cancerJournal of Experimental & Clinical Cancer Research 2011; 30(1) doi: 10.1186/1756-9966-30-107
38
Theodora Tzanavari, Jason Tasoulas, Chrysoula Vakaki , Chrysovalantou Mihailidou , Gerasimos Tsourouflis , Stamatios Theocharis . The Role of Adipokines in the Establishment and Progression of Head and Neck NeoplasmsCurrent Medicinal Chemistry 2019; 26(25): 4726 doi: 10.2174/0929867325666180713154505
39
Suzanne W. Chang, William S. Pan, Daniel Lozano Beltran, Lizet Oleyda Baldelomar, Marco Antonio Solano, Iskra Tuero, Jon S. Friedland, Faustino Torrico, Robert H. Gilman, Robert J. Wilkinson. Gut Hormones, Appetite Suppression and Cachexia in Patients with Pulmonary TBPLoS ONE 2013; 8(1): e54564 doi: 10.1371/journal.pone.0054564
40
R Dev, E Bruera, S Dalal. Insulin resistance and body composition in cancer patientsAnnals of Oncology 2018; 29(suppl_2): ii18 doi: 10.1093/annonc/mdx815
41
Josep M. Argilés, Britta Stemmler, Francisco J. López-Soriano, Silvia Busquets. Inter-tissue communication in cancer cachexiaNature Reviews Endocrinology 2019; 15(1): 9 doi: 10.1038/s41574-018-0123-0
42
J.T Dwarkasing, D.L. Marks, R.F Witkamp, K. van Norren. Hypothalamic inflammation and food intake regulation during chronic illnessPeptides 2016; 77: 60 doi: 10.1016/j.peptides.2015.06.011
43
Maria Dalamaga. Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectivesBiomarkers in Medicine 2014; 8(1): 107 doi: 10.2217/bmm.13.99
44
Elisavet K. Tiaka, Anastassios C. Manolakis, Andreas N. Kapsoritakis, Spyros P. Potamianos. The implication of adiponectin and resistin in gastrointestinal diseasesCytokine & Growth Factor Reviews 2011; 22(2): 109 doi: 10.1016/j.cytogfr.2011.04.002
45
Oliver Grundmann, Saunjoo L. Yoon, Joseph J. Williams. Handbook of Famine, Starvation, and Nutrient Deprivation2019; : 943 doi: 10.1007/978-3-319-55387-0_56
46
Takako Eguchi Nakajima, Yasuhide Yamada, Tetsutaro Hamano, Koh Furuta, Takuji Gotoda, Hitoshi Katai, Ken Kato, Tetsuya Hamaguchi, Yasuhiro Shimada. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancerJournal of Gastroenterology 2009; 44(7): 685 doi: 10.1007/s00535-009-0063-5
47
Josep M. Argilés, Sílvia Busquets, Britta Stemmler, Francisco J. López-Soriano. Cancer cachexia: understanding the molecular basisNature Reviews Cancer 2014; 14(11): 754 doi: 10.1038/nrc3829